Dahlen tapped as NeuroSearch CEO

NeuroSearch has named Patrik Dahlen as the new CEO of the company, replacing Flemming Pedersen, who has resigned to take up a new position in another company. NeuroSearch release Torbjorn Bjerke has been appointed as new CEO for Karolinska Development. He is currently CEO for Orexo, a position he has held since 2007. Karolinska Development release Caris Life Sciences has announced that Winston K.C. Lam has joined the company as executive VP, business development and chief legal...

Amarin picks Colin Stewart as president, CEO

Amarin has tapped Colin Stewart as president, CEO and a member of the company's board of directors. Amarin release SkyePharma has appointed Axel Müller as CEO with effect from Aug. 23. Skyepharma release Werner Cautreels has been selected as president and CEO of Selecta Biosciences, a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies. Selecta release Alimera Sciences has promoted Richard Eiswirth, Jr. to chief operating officer and...

Signum names Shroot as CEO

Signum Biosciences has appointed Braham Shroot, formerly CSO of Barrier Therapeutics, as CEO. Shroot replaces Gregory Stock, who will continue to remain active with the company as a member of the board. Signum release Renhuang Pharmaceuticals has announced that company CFO Yan Yi Chen has resigned for personal reasons effective immediately. Renhuang release Orexo has appointed Robin Wright as EVP head of finance, replacing Claes Wenthzel who, after five years in the group, has...

CMP Therapeutics names Neill Moray Mackenzie CEO

CMP Therapeutics has named Neill Moray Mackenzie as CEO. CMP release Aragon Pharmaceuticals has named Richard Heyman to the role of CEO. In addition, scientists Ronald Evans, an expert in the area of hormone research and transcriptional regulation, and David Mangelsdorf, an authority on nuclear receptors and endocrine signaling, were added to the company's scientific advisory board. Aragon release CT Atlantic taps Michael Höcker to become CEO. CT release Tengion has appointed A. Brian...

Ambit taps Alan Lewis as CEO

Ambit Biosciences has completed a thorough executive search and appointed Alan Lewis as chairman and CEO of the company. Release Ablynx Chief Scientific Officer Debbie Law has resigned from her position at Ablynx. Release iBio has named Terence (Terry) Ryan as senior VP, business development. Release Roche has announced that Karen Lackey has been named VP and head of medicinal chemistry, effective immediately. Release Gentris has appointed Karen Weck as a consulting medical director. Dr....

Taris names Duddu president, CEO

> Taris Biomedical has named Sarma Duddu president and CEO and a member of the board of directors, effective immediately. Release > Amgen has tapped Jonathan Peacock as CFO, effective Sept. 1. Release > K-V Pharmaceutical has announced that Thomas McHugh has been appointed CFO, effective immediately. Release > Spectrum Pharmaceuticals has named George Tidmarsh to the position of senior VP, chief scientific officer and head of R&D operations. Release > Phage...

Former Pfizer exec heads to Berlin Pharmaceutical Industry

> Berlin Pharmaceutical Industry, Thailand's leading manufacturer and marketer of generic pharmaceuticals, has named Amal Naj, a former senior VP at Pfizer, CEO and a member of the board. Release > Vitae Pharmaceuticals today announced the appointment of Christine Brennan as chief business officer. Release > Timothy Hayes, currently senior VP and region head for Bayer HealthCare's consumer care division in North America, will also lead the business unit's global business...

AlloCure taps Brenner as president, CEO

AlloCure has appointed Robert Brenner as president and CEO. Release Lux Biosciences has named Dean Mitchell as president and CEO. Mitchell is the former president and CEO of Alpharma. Release Jiangbo Pharmaceuticals has tapped Linxian Jin as the company's CEO. Jin will take over the role of CEO from Chairman Wubo Cao, who resigned on June 29. Cao will continue his role as chairman of the company's board. Release James Connolly has been named president and CEO of the...

Noxxon’s Morich to leave in August

Germany's Noxxon Pharma has announced that CEO Frank Morich will leave the company effective Aug. 15 to take up the position executive VP, international operations, at Takeda Pharmaceutical Company Limited. Iain Buchanan will assume the role of interim CEO  and will support the board during its search for a permanent replacement. Release Bind Biosciences has appointed Ed Schnipper as chief medical officer. Release Michael Tremblay has been appointed president of the Canadian...

Claudio Albrecht to become Actavis CEO

Claudio Albrecht is set to become the new CEO of Actavis Group. Release Phytopharm has appointed Tim Sharpington as CEO and board director. Release Jennerex has announced the appointment of Gregory Schafer as senior VP and CFO. Release Farouk Dakhil has been named Xytos' new chief scientific officer and the head of its scientific advisory board. Release BrainStorm Cell Therapeutics has named Liat Sossover as its CFO. Release Spectrum Pharmaceuticals has appointed James Shields to...